ARDX

ARDELYX, INC.

ARDELYX, INC. (ARDX) has 19 SEC Form 4 filings (36 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Jul 17, 2026.

The most active filer is President & CEO RAAB MICHAEL with 4 filings. Insiders have net sold $1.7M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Michael G. Raab
  • Employees:489
  • HQ:Waltham, MA, US
  • IPO:2014-06-19

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.7M

reported sales (SEC code S)

Unique Insiders

8

in the rolling window

Market Cap

$1.3B

latest known value

Source
Sale$211KJul 17SEC ↗
Sale$490KJun 22SEC ↗
Sale$236KJun 17SEC ↗
Sale$343KMay 22SEC ↗
Williams Laura AFirst filing
Sale$44KMay 22SEC ↗
Kelliher MikeFirst filing
Sale$45KMay 22SEC ↗
Foster Eric DuaneFirst filing
Sale$50KMay 22SEC ↗
Sale$23KMay 22SEC ↗
Hohenleitner SusanFirst filing
Sale$9KMay 22SEC ↗
Brady James ParkerFirst filing
Sale$12KMay 22SEC ↗
Bishop John EFirst filing
Sale$14KMay 22SEC ↗
RAAB MICHAELFirst filing
Sale$262KMay 19SEC ↗

Related companies

ARDELYX, INC. is in the Healthcare sector.